National Institutes of Health (NIH)
The National Institutes of Health, Department of Health and Human Services has announced the following new funding opportunity:
BRAIN Initiative: Development and Validation of Novel Tools to Analyze Cell-Specific and Circuit Specific Processes in the Brain (U01)
Ohio Third Frontier (OTF), Ohio Development Services Agency
The goal of the Ohio Third Frontier Technology Validation and Start-Up Fund (TVSF) is to increase economic growth in Ohio through start-up companies that commercialize technologies developed by Ohio institutions of higher education and other Ohio not-for-profit research institutions. Two separate mechanisms have been set up to achieve these goals:
Phase 1 –Technology Validation The specific objectives of this phase are as follows:
• To generate the proof needed to move technology to the point that it is either ready to be licensed by an Ohio start-up company or otherwise deemed unfeasible for commercialization.
• To fund validation activities, such as prototyping, demonstrations, and assessment of critical failure points in subsequent development, scale-up, and commercialization.
Phase 2 – Start-Up Funds The specific objectives of this phase are as follows:
• To support Ohio start-up companies that have licensed technology developed at Ohio research institutions during the critical early life of the company, and accelerate the time to market of this technology.
• To generate the proof needed to either commercialize the technology or move the technology to the point where additional funds needed for commercialization can be raised.
• To fund activities in order to generate the needed proof.
The TVSF will support technology that falls within the following areas: Advanced Materials related to advanced polymers, ceramics, composites, carbon fibers and nanotubes and specialty metals and alloys; Aeropropulsion Power Management; Agribusiness and Food Processing; Fuel Cells and Energy Storage; Medical Technology related to imaging, surgical instruments/equipment, implant devices, and regenerative medicine; Software Applications for business and healthcare; Sensing and Automation Technologies; Situational Awareness and Surveillance Systems; Solar Photovoltaics; and Shale.
Potential CWRU Applicants - Contact:
Michael Haag, MS, MBA, Executive Director, Technology Management, 216-368-6106 or firstname.lastname@example.org.
For more information on the TVSF visit the Ohio Third Frontier website.
Hands-on Introduction to the New Sparta COI System
Nursing School Bioinformatics Lab, Ground Floor
Wednesday, February 4, 2015 - 10:00 - 11:00am
Wednesday, February 11, 2015 - 10:00 - 11:00am
Wednesday, February 18, 2015 - 10:00 - 11:00am
School of Medicine, Robbins E324
Thursday, February 5, 2015 - 2:00 - 3:00pm
Wednesday, February 18, 2015 - 2:00 - 3:00pm
Tuesday, March 17, 2015 - 2:00 - 3:00pm
Kelvin Smith Library
Monday, February 9, 2015 - 10:00 – 11:00am - Room LL06
Friday, February 20, 2015 - 2:00 – 3:00pm - Room 215
Join the Office of Research Administration Conflict of Interests (COI) staff for an opportunity to learn about the new Sparta COI software for the annual disclosure process. Attendees can stop in for a quick tutorial of the new system, or you can complete your disclosure during the session with assistance from our COI staff.
Registration is online at: https://research.case.edu/Education/Onlinecalendar.cfm.
amfAR, The Foundation for AIDS Research
amfAR, The Foundation for AIDS Research, has announced the availability of funding to support research relevant to exploring HIV persistence and the potential for HIV eradication. amfAR has established a new funding mechanism known as Impact Grants to support the in-depth development of concepts where preliminary data have indicated genuine promise in curing HIV. Impact Grants are conducted over a four-year funding period with up to $2,000,000 in total funding (including up to 20% indirect costs) and should include basic, animal and clinical (in vivo or ex vivo) research. Impact Grants aim to directly inform clinical efforts to safely eliminate or control latent/persistent HIV reservoirs. Priority will be given to projects with a clear pathway to development of an implementable intervention in humans.
Total Cost Maximum: $2,000,000
Performance Period: 4 years (July 1, 2015 – June 30, 2019)
Portal Request Form Deadline: Friday, February 27, 2015, 3:00 PM ET
Letter of Intent Submission Deadline: Tuesday, March 3, 2015, 3:00 PM ET
Hardcopy of Signed Face Page By Mail: Tuesday, March 24, 2015
For more information and to review the complete RFP visit the amfAR website.
FBI Talk on International Travel
Monday, February 9, 2015
12 pm - 1 pm
Toepfer Room, Adelbert Hall
Are you a researcher who travels abroad to attend scientific or academic conferences? To meet with potential sponsors, donors, or collaborators? To teach at a foreign university or travel with students on an international trip?
Join FBI representatives who will present cutting-edge information on travel concerns for university faculty and employees traveling abroad.
There is no pre-registration. Seating is limited and is first come, first seated.
For more information, contact Lisa Palazzo, Director of Export Control and Privacy Management, at 216.368.5791 or email@example.com, or Boyd Kumher, University Chief Compliance, Export Control and Privacy Officer, at 216.368.0833 or firstname.lastname@example.org.
If you have news or information that you wish to have included in this
update, please send it via e-mail to Tracy Wilson-Holden at
email@example.com no later than
5 pm on the Monday of the week that the update is to be distributed. If you
know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe
to Case Research News, email your request to Tora Williams at
Please note: At the time of this transmission, all links functioned.
However, Case Research News cannot guarantee that the information will not move or be